An Internet-based application fostering a global collaboration for External Quality Assessment Schemes for Nucleic Acid Testing Thu-Anh Pham 1, Dimech.

Slides:

Advertisements

Similar presentations

HCV Assays: Impact on HCV Studies & Update on HCV blood bank protocol.

Advertisements

Assuring the Quality of Samples for Proficiency Testing or External Quality Assessment Schemes Terminology External quality assessment is a method for.

Istituto Superiore di Sanità Laboratory of Immunology External quality assessment for detection by NAT of the six major HCV genotypes M Wirz*, GM Bisso*,

Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.

Yi-Chen Yang, Drug Biology Division Bureau of Food and Drug Analysis Department of Health, Taiwan Collaborative study for establishment of the first national.

Karen Cristiano Biologicals Unit, CRIVIB Calibration against the WHO Standards of National Reference Preparations for detection of blood viruses by NAT:

Is Nucleic Acid Testing for Organ Donors the ‘Right’ Choice? Reference: Humara A, Morrisb M, Blumbergc R, et al. Nucleic acid testing (NAT) of organ donors:

Quality Assurance Programmes for Laboratory Testing - An Overview Elizabeth M. Dax National Serology Reference Laboratory, Australia Elizabeth.

Htay Htay Tin, Khin Yi Oo, Latt Latt Kyaw, Win Win Yee, Tin Tin Htay

F. Kourgia, M. Vini, E. Zervou

COBAS TaqMan 48 Sales Brochure

R Diagnostics June 19, 2003 WNV FDA BPAC MeetingPCR NAT Blood Screening TaqScreen West Nile Virus Program - Roche Update James L. Gallarda, Ph.D. Roche.

PROFICIENCY TESTING OF IN-HOUSE NAT ASSAYS USED FOR BLOOD SCREENING XXI SoGAT International Working Group Meeting on the Standardization of NAT for the.

Organ Donor Infectious Disease Testing Education UW Health OPO July 2009.

CE MARKING OF IVDDs - the NIBSC perspective Morag Ferguson Division of Virology.

21th VHPB meeting on “Prevention of viral hepatitis in Italy: lessons learnt and the way forward” Catania, 7-8 november 2002 RESIDUAL RISK OF TRANSFUSION-

EQASs for Blood Borne Virus Genomes and BSE Prions from Cattle Brain and INSTAND Reference Materials H.-P. Grunert 1,2, K.-O. Habermehl 1,2, V. Lindig.

The concept for a network of national Reference Laboratories for high risk IVDs – Results of the working group meeting 1.

Yi-Chen Yang, Yu-Hsuan Chen, Show-Lan Chiu, Hwei-Fang Cheng Drug Biology Division, Bureau of Food and Drug Analysis Department of Health, Taiwan, ROC National.

Treat Asia Quality Assurance Scheme Supported by AMFAR and coordinated by the National Reference Laboratory in Australia Sally Land.

Sensitivity of NAT blood screening assays in performance evaluation and proficiency programs Harry van Drimmelen, Nico Lelie, (VQC-Sanquin) and the principal.

SoGAT XVII/Paris, 2004 Proficiency Testing of In-House Developed HIV-1 NAT for Blood Screening Michael Chudy, Paul-Ehrlich-Institut Division of Virology,

Monitoring the Performance of Nucleic Acid Tests using Data Generated from EDCNet and DigitalPT Wayne Dimech, Darren Jardine, Thu-Anh Pham and the staff.

1 Procleix ® WNV Assay: A TMA-based Assay for Screening Blood Donations for West Nile Virus RNA Jeff Linnen, Ph.D. Research and Development Gen-Probe Incorporated,

QUALITY ASSURANCE GUIDELINES HONWANI F.J Q.A ON RAPID HIV TESTING 10 AUGUST 2010.

The Use of Pooled Viral Load Testing to Identify Antiretroviral Treatment Failure Davey Smith 1, Susanne May 2, Josué Perez-Santiago 1, Matthew Strain.

Review of Site Visit Report Laboratory of Molecular Virology DETTD/OBRR/CBER March 18, 2005 Hira L. Nakhasi, Ph.D. Director, DETTD.

History of ILC Involvement in NAT Standardization 1998: Inter-Organization Discussion for the Establishment of Standard Reference Material for Nucleic.

Ongoing Standardisation of Testing for Blood-Borne Pathogens through an Internet-based Application Elizabeth M. Dax for the staff of the National Serology.

Blood Products & related Biologicals: SoGAT, 28 May 09 1 |1 | Dr Ana Padilla, Blood Products & related Biologicals Essential Medicines and Pharmaceutical.

Update on the P. falciparum Standard & Replacement of the HBV & HCV International Standards Sally Baylis, NIBSC SoGAT XIX.

Performance of Chiron Quantitative and Qualitative HBV PCR Assay and Confirmation of HBV Yield Cases Yiu-Lian Fong, Ph.D, Associate Director June 13, 2007.

A multi-centre NAT evaluation study of run and trend control samples Harry van Drimmelen 1, Joe O’Donnellan 2, Rene Bax 1, Henrik Ullum 3 and the Danish.

ADAP and Hepatitis B Coverage  In June 2012, 29 ADAPs covered at least one of the medications for HBV on their formularies.  ADAPs filled 325 hepatitis.

Paul Klapper Clinical Virology Manchester Royal Infirmary hepatitis C dried blood spot testing.

NUCLEIC ACID AMPLIFICATION TECHNOLOGY HCV-RNA / HBV-DNA / HIV-RNA testing blood and blood components for transfusion Italian External Quality Assessment.

Ad Hoc Disease Transmission Advisory Committee Fall 2014.

Dr. Gamaliel Gutiérrez Regional Dengue Program PAHO/WHO WDC

Preparation of HBV DNA reference standards and the experience of HBV NAT in Taiwan Dr. Hwei-Fang Cheng Department of Health, Taiwan.

PROPOSED CANDIDATE MATERIAL FOR A WHO PANEL FOR SEROLOGICAL REFERENCE RESULTS OF THE FEASIBILITY STUDIES WITH SERA FROM TC I REGION RESULTS OF THE FEASIBILITY.

MTN-016 TRAINING Infant HIV Testing Urvi M Parikh, Ph.D. University of Pittsburgh Pittsburgh, PA USA.

A Universal Testing Programme for Blood Borne Viruses in an Urban Emergency Department – a call for widespread ED testing in Ireland S O’Connell 1, D Lillis.

Ad Hoc Disease Transmission Advisory Committee Fall 2014.

An Overall View of Standardization May 26, 2004 Indira Hewlett, Ph.D. CBER/FDA.

THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Evaluation of two techniques for viral load monitoring on DBS ANRS project Phase I - Laboratory.

Quality Assessment for Blood Screening Laboratories in Australia and the Asian Pacific. Darren Jardine and Staff of the National Serology Reference Laboratory,

February 24, 2016 | 1 Paul Strengers MD, FFPM Sanquin Blood Supply Amsterdam The Netherlands Risk assessment schemes: Impact of.

CBER Update on status of West Nile virus test, lot release and validation panel development Indira Hewlett, Ph.D CBER/FDA Blood Products Advisory Committee.

Informational Presentation: WHO Biological Standards Summary of January 29-30, 2007 WHO Meeting with WHO Collaborating Centres for Biological Standards.

Progress on Study to Validate Synthetic Materials for Use as Calibrators and References SoGAT XIX Bern, 14 June 2006 Roberta M. Madej Roche Molecular Diagnostics.

Prevalence of Chlamydia and Gonorrhea Among Patients With Genital Ulcer Disease in Zimbabwe: Potential Implications for Syndromic Management More Mungati:

11/21/2014 CFAR Mentoring Core Facilities at UCSF and Beyond Teri Liegler, PhD Director ARI-UCSF Laboratory of Clinical Virology CFAR Virology Core Laboratory.

LOW HCV PREVALENCE AMONG HIV+ INDIVIDUALS IN SUB-SAHARAN AFRICA

Saeko Mizusawa, Yoshiaki Okada

Update: DigitalPT EQA Collaboration

TRANSFUSION: Blood donation and preparation of blood components

Organ Donor Infectious Disease Testing Education

2011 American Society for Microbiology Meeting

Results of Recent EQA Panels for Blood Borne Viruses

Factor xiiia enzyme Human Factor XIII is cleaved with human alpha thrombin. The thrombin is subsequently removed via chromatography. The above protein.

Longitudinal Quality Assurance of HIV Nucleic Acid Testing in Blood Screening D Jardine, S Best, EM Dax (National Serology Reference Laboratory, Australia)

مدیریت امور آزمایشگاهها دانشگاه علوم پزشکی کاشان

Evaluation of the Patient With HCV Infection

Evaluation data on the new Roche cobas s 201 system with the cobas TaqScreen MPX test Lutz Pichl, Volkmar Schottstedt German Red Cross Blood Transfusion.

Italian EQA study for HCV RNA, HIV RNA and HBV DNA G. M. Bisso, K

NUCLEIC ACID AMPLIFICATION TESTING DETECTS HIV TRANSMISSION RISK IN SEROLOGICALLY- TESTED BLOOD DONOR UNITS. |Presented by Miss Shemau Muniru| Authors:

2018 Postgraduate Research Symposium: Exploring opportunities

SoGAT meeting XXI May (2009), Brussels, Belgium

Assessment of risk factors for hepatocellular carcinoma in HIV care and treatment programs across 31 countries: a cross-sectional survey within IeDEA C.

ANALYTICAL CONTROL SYSTEM AS A MEASURE TO ENSURE INFECTIOUS SAFETY OF HUMAN PLASMA FOR FRACTIONATION A.L. Poptsov FSBI “ROSPLASMA” RMSPC of FMBA of RUSSIA.

Presentation transcript:

An Internet-based application fostering a global collaboration for External Quality Assessment Schemes for Nucleic Acid Testing Thu-Anh Pham 1, Dimech W 1, Ho A 2, Jardine D 1, Walker S 1, van Drimmelen H 3 and Dax EM 1 1 National Serology Reference Laboratory, Australia (NRL) 2 HealthMetrx, Canada 3 AcroMetrix, USA/ The Netherlands

NRL EQAS External Quality Assessment Schemes EQAS provider for over 15 years Serology: HIV, HCV, HTLV, HBV, CMV, Syphilis NAT: HIV, HCV, HBV, CT/NG, Blood Screening (HIV/HCV), Genotyping (HIV/ HCV), HAV, CMV, Parvovirus B19, HSV- 1/2, Blood Screening HBV Aims of EQAS

Fostering Global Collaboration Aims of Global Collaboration: Provide well-characterised samples from all over the world Improve submission of results Improve turnaround time of reports Expansion of schemes offered

Facilitating Global Collaboration ( Develops and manufactures standards, run controls, proficiency and evaluation panels HealthMetrx ( ) Leading EQAS provider in Canada Developed

Results of Global Collaboration Table 1: The number of NRL participants that used DigitalPT in 2005 Manual n (%) DigitalPT n (%) HIV6 (20)24 (80) HCV6 (15)34 (85) HBV5 (26)14 (74)

Results of Global Collaboration Table 2: The number of participants enrolled in NRL NAT EQAS QL: QualitativeVL: Viral Load Scheme (May) HIV VL HCV 3840 VL = 24 QL = 37 HBV 1320 VL = 27 QL = 3 Parvovirus B19 QL 7 HSV-1/2 QL 13 CMV VL = 8 QL = 5 HAV QL 6

Laboratory Gains Rapid turnaround time of final reports Each laboratory received individualised results summary Compare results reported by laboratories Benchmarking

Summary of Global Collaboration